Welcome To The Week In Review.

  1. Inflation Reduction Act: A Victory For Patients

2. Big Pharma Watchdog Alerts

3. Spotlight on Congress: Drug Prices Matter

BONUS: This #WorldAIDSDay, we recognized that people living with HIV/AIDS face exorbitant prices for essential drugs because of price gouging from Big Pharma. Gilead Sciences, which has a monopoly on many essential HIV and AIDS medications, price gouges patients taking its HIV antiviral treatment Biktarvy, charging more than $3,500 a month for a drug that is keeping people alive. We must continue to fight for equitable access to life-saving drugs. 

Have a great weekend, everyone!